Virtus Fund Advisers’s Amphastar Pharmaceuticals AMPH Stock Holding History

Virtus Fund Advisers’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$45.3K	Buy	1,220 +42	+4%	+$1.92K	0.14%	73
2024 Q3	$57.2K	Hold	1,178	–	–	0.23%	56
2024 Q2	$47.1K	Buy	1,178 +88	+8%	+$3.65K	0.19%	63
2024 Q1	$47.9K	Buy	1,090 +109	+11%	+$5.63K	0.17%	66
2023 Q4	$60.7K	Hold	981	–	–	0.38%	41
2023 Q3	$45.1K	Hold	981	–	–	0.32%	54
2023 Q2	$56.4K	Buy	+981	New	+$43.5K	0.4%	44

Other funds holding AMPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Virtus Fund Advisers's AMPH Position: Q4 2024 in Review

Virtus Fund Advisers increased its Amphastar Pharmaceuticals (AMPH) stake by 3.6% in Q4 2024, buying an estimated $1.92K and bringing the position to 1,220 shares worth $45.3K. The position accounts for 0.14% of the portfolio, ranked #73.

Virtus Fund Advisers first reported a position in AMPH in Q2 2023 and has held it in 7 quarters since. The position peaked at $60.7K in Q4 2023. 263 funds tracked by Wall St. Rank hold AMPH as of Q4 2024.

Virtus Fund Advisers held 1,220 shares of Amphastar Pharmaceuticals worth $45.3K as of Q4 2024.
Virtus Fund Advisers bought 42 Amphastar Pharmaceuticals shares in Q4 2024, an estimated $1.92K.
Amphastar Pharmaceuticals made up 0.14% of Virtus Fund Advisers's portfolio in Q4 2024, its #73 holding.
Virtus Fund Advisers first reported a position in Amphastar Pharmaceuticals in Q2 2023 and has held it in 7 quarters since.
Virtus Fund Advisers's Amphastar Pharmaceuticals position peaked at $60.7K in Q4 2023.
263 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2024.

Based on Virtus Fund Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.